A phase Ib study of a PI3Kinase inhibitor BKM120 in combination with panitumumab in patients with KRAS wild-type advanced colorectal cancer
Goodwin, Rachel, Jonker, Derek, Chen, Eric, Kennecke, Hagen, Cabanero, Michael, Tsao, Ming-Sound, Vickers, Michael, Bohemier, Caryn, Lim, Howard, Ritter, Heather, Tu, Dongsheng, Seymour, LesleyJournal:
Investigational New Drugs
DOI:
10.1007/s10637-019-00814-3
Date:
September, 2019
File:
PDF, 331 KB
2019